Published in Am J Clin Pathol on June 01, 1997
Leukemic vasculitis: a newly described pattern of cutaneous involvement. Am J Clin Pathol (1997) 0.75
Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol (2000) 3.42
Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst (1996) 3.23
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68
Tetraspanin CD151 plays a key role in skin squamous cell carcinoma. Oncogene (2012) 2.16
Cytology of typical and atypical Ewing's sarcoma/PNET. Am J Clin Pathol (1996) 2.14
The 35-nucleotide spliced leader sequence is common to all trypanosome messenger RNA's. Science (1986) 2.14
A factual, not arbitrary, basis for choice of resection margins in melanoma. Arch Dermatol (1996) 2.12
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06
Cellular angiofibroma: a benign neoplasm distinct from angiomyofibroblastoma and spindle cell lipoma. Am J Surg Pathol (1997) 2.04
Reliability of the histopathologic diagnosis of melanocytic dysplasia. The Dysplastic Nevus Panel. Arch Dermatol (1997) 2.02
A quantitative model of invasive Pseudomonas infection in burn injury. J Burn Care Rehabil (1994) 1.91
Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc Natl Acad Sci U S A (1996) 1.80
A nonerythroid GATA-binding protein is required for function of the human preproendothelin-1 promoter in endothelial cells. Mol Cell Biol (1990) 1.76
Spitz tumors in children: a grading system for risk stratification. Arch Dermatol (1999) 1.71
DAZ family proteins exist throughout male germ cell development and transit from nucleus to cytoplasm at meiosis in humans and mice. Biol Reprod (2000) 1.64
A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi. J Am Acad Dermatol (1994) 1.64
Nevomelanocytic proliferations in association with cutaneous malignant melanoma: a multivariate analysis. J Am Acad Dermatol (1989) 1.59
Papanicolaou smear sensitivity for adenocarcinoma in situ of the cervix. A study of 34 cases. Am J Clin Pathol (1997) 1.46
Renal cell carcinomas in children and young adults: increased incidence of papillary architecture and unique subtypes. Am J Surg Pathol (1999) 1.44
Characterization of the 1.35 kilobase DNA repeat unit containing the conserved 35 nucleotides at the 5'-termini of variable surface glycoprotein mRNAs in Trypanosoma brucei. Nucleic Acids Res (1984) 1.42
Characterization of the Trypanosoma brucei 5S ribosomal RNA gene and transcript: the 5S rRNA is a spliced-leader-independent species. Gene (1985) 1.42
Adenocarcinoma in situ in cervical smears with a small cell (endometrioid) pattern: distinction from cells directly sampled from the upper endocervical canal or lower segment of the endometrium. Am J Clin Pathol (1998) 1.40
Kikuchi-Fujimoto disease of the neck. Update. Ann Otol Rhinol Laryngol (1993) 1.38
Comparison of functional testing for resistance to activated protein C and molecular biological testing for factor V R506Q in 370 patients. Arch Pathol Lab Med (1998) 1.37
The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia. Blood (2000) 1.35
The polymerase chain reaction colony miniprep. Biotechniques (1990) 1.35
Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement. Am J Surg Pathol (2000) 1.35
Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases. Cancer (1995) 1.33
Expression of sialyl-Lewis X, an E-selectin ligand, in inflammation, immune processes, and lymphoid tissues. Am J Pathol (1992) 1.29
Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma. Int J Cancer (1993) 1.27
Inflammatory pseudotumor of lymph node and spleen: an entity biologically distinct from inflammatory myofibroblastic tumor. Hum Pathol (2001) 1.27
Sunlamp use and the risk of cutaneous malignant melanoma: a population-based case-control study in Connecticut, USA. Int J Epidemiol (1998) 1.21
The spliced leader sequence of Trypanosoma brucei has a potential role as a cap donor structure. Mol Cell Biol (1985) 1.15
Desmoplastic melanoma. Histopathology (1992) 1.14
CT and ultrasound features of metanephric adenoma in adults with pathologic correlation. J Comput Assist Tomogr (1999) 1.13
Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Blood (2000) 1.12
Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma. Am J Surg Pathol (1998) 1.11
Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. Cancer Res (1996) 1.10
Clinical diagnosis of pigmented lesions using digital epiluminescence microscopy. Grading protocol and atlas. Arch Dermatol (1993) 1.08
Borrelial fasciitis: diffuse fasciitis and peripheral eosinophilia associated with Borrelia infection. Am J Dermatopathol (1996) 1.07
Atypical or worrisome features in cellular neurothekeoma: a study of 10 cases. Am J Surg Pathol (1998) 1.07
Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions. J Am Acad Dermatol (1982) 1.07
Regulated expression of endothelin 1 in glomerular capillary endothelial cells. Am J Physiol (1991) 1.06
Cytologic findings in granular cell tumors, with emphasis on the diagnosis of malignant granular cell tumor by fine-needle aspiration biopsy. Cancer (2001) 1.05
The 5.8S ribosomal RNA gene of Trypanosoma brucei: structural and transcriptional studies. Nucleic Acids Res (1985) 1.05
Patient knowledge, awareness, and delay in seeking medical attention for malignant melanoma. J Clin Epidemiol (1999) 1.04
DNA rearrangements of the variable surface antigen genes of the trypanosomes. J Protozool (1984) 1.04
Unbalanced expression of bcl-2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival. Blood (1998) 1.04
Analysis of vascularity of human neurofibromas. J Am Acad Dermatol (1998) 1.03
Increased thickness of pregnancy-associated melanoma. Br J Dermatol (1995) 1.02
Fine-needle aspiration of the adult kidney. Cancer (1997) 1.00
Treatment of minocycline-induced hyperpigmentation with the Q-switched ruby laser. Arch Dermatol (1996) 0.99
My approach to atypical melanocytic lesions. J Clin Pathol (2004) 0.98
Epidermal growth factor, estrogen, and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas. Mod Pathol (1999) 0.98
Murine cytotoxic T lymphocytes recognize an epitope in an EBNA-1 fragment, but fail to lyse EBNA-1-expressing mouse cells. J Exp Med (1998) 0.98
Histologic regression in malignant melanoma: an interobserver concordance study. J Cutan Pathol (1993) 0.97
Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma. Br J Dermatol (2006) 0.96
Primary marginal zone lymphoma of the thymus. Am J Clin Pathol (2000) 0.95
Malignant melanoma risk factors by anatomic site: a case-control study and polychotomous logistic regression analysis. Int J Cancer (1996) 0.95
Restriction of neuroblastoma to the prostate gland in transgenic mice. Mol Cell Biol (1991) 0.95
Validation of a melanoma prognostic model. Arch Dermatol (1998) 0.95
Multiple primary cutaneous melanomas. Cancer (1992) 0.95
Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases. Cancer (2001) 0.95
Targeting of transgene expression to monocyte/macrophages by the gp91-phox promoter and consequent histiocytic malignancies. Proc Natl Acad Sci U S A (1991) 0.94
Characteristic proliferations of reticular and dendritic cells in angioimmunoblastic lymphoma. Am J Surg Pathol (1998) 0.94
Histopathologic recognition and grading of dysplastic melanocytic nevi: an interobserver agreement study. J Invest Dermatol (1993) 0.93
Effusion cytology of renal cell carcinoma. Cancer (1998) 0.93
The Spitz tumor 50 years later: revisiting a landmark contribution and unresolved controversy. J Am Acad Dermatol (1999) 0.92
Adenoid basal carcinomas of the cervix: a unique morphological evolution with cell cycle correlates. Hum Pathol (2000) 0.92
Small cell sweat gland carcinoma in childhood. Am J Surg Pathol (1998) 0.92
Primary malignant melanoma of the external auditory canal: a case report with presentation as an aural polyp. Am J Otol (1992) 0.91
The T-cell activation markers CD30 and OX40/CD134 are expressed in nonoverlapping subsets of peripheral T-cell lymphoma. Blood (1999) 0.91
Histologic spectrum of cutaneous involvement in patients with myelogenous leukemia including the neutrophilic dermatoses. Int J Dermatol (1995) 0.90
Splenic pathology in myelodysplasia: a report of 13 cases with clinical correlation. Am J Surg Pathol (1998) 0.90
Postpartum and vulvar necrotizing fasciitis. Early clinical diagnosis and histopathologic correlation. J Reprod Med (1998) 0.90
Expression of monocyte chemoattractant protein-1 in delayed type hypersensitivity reactions in the skin. Lab Invest (1994) 0.90
Lesions resembling malignant atrophic papulosis in a patient with dermatomyositis. J Am Acad Dermatol (1997) 0.90
Malignant melanoma in situ: functional considerations of cancer. Hum Pathol (1990) 0.88
Expression of MHC class II-associated invariant chain (Ii;CD74) in thymic epithelial neoplasms. Appl Immunohistochem Mol Morphol (2000) 0.87
Evaluation of factors associated with skin self-examination. Cancer Epidemiol Biomarkers Prev (1999) 0.87
Common acquired melanocytic nevi, dysplastic melanocytic nevi and malignant melanomas: an image analysis cytometric study. J Cutan Pathol (1993) 0.86
Interobserver reproducibility of ulceration assessment in primary cutaneous melanomas. Eur J Cancer (2003) 0.86
C16 laminin peptide increases angiotropic extravascular migration of human melanoma cells in a shell-less chick chorioallantoic membrane assay. Br J Dermatol (2007) 0.86
A comparison of A103 and inhibin reactivity in adrenal cortical tumors: distinction from hepatocellular carcinoma and renal tumors. Mod Pathol (1998) 0.86
Ultrastructural and immunohistochemical studies of the periendothelial matrix in human melanoma: evidence for an amorphous matrix containing laminin. J Cutan Pathol (1999) 0.86
Spontaneous regression of cutaneous tumors. Adv Dermatol (1993) 0.86
The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides. Am J Clin Pathol (2001) 0.86
Diagnosing lymphoproliferative disorders involving the cerebrospinal fluid: increased sensitivity using flow cytometric analysis. Diagn Cytopathol (2000) 0.85
Hormonal and reproductive influences and risk of melanoma in women. Int J Epidemiol (1998) 0.85
The importance of elastic fibres in skin lymphatics. Br J Dermatol (1983) 0.85
Morphological analysis of nevoid melanoma: a study of 20 cases with a review of the literature. Am J Dermatopathol (2001) 0.85
Fine needle aspiration of chromophobe renal cell carcinoma. Acta Cytol (1996) 0.84
Bile duct brushing cytology: statistical analysis of proposed diagnostic criteria. Am J Clin Pathol (1998) 0.84
Non-Hodgkin's lymphomas: current classification and management. CA Cancer J Clin (1997) 0.84
Melanoma and extravascular migratory metastasis. J Cutan Pathol (2000) 0.84
Epidemiology of cutaneous melanoma. An update. Dermatol Clin (1991) 0.84
Malignant blue nevus. Case report and literature review. J Am Acad Dermatol (1988) 0.84
Tumor microvessels in melanoma express the beta-2 chain of laminin. Implications for melanoma metastasis. J Cutan Pathol (1999) 0.84
Pagetoid Spitz nevus. Intraepidermal Spitz tumor with prominent pagetoid spread. Am J Surg Pathol (1995) 0.83
Tumour vascularity is not a prognostic factor for cutaneous melanoma. Lancet (1994) 0.83